Mangalam Drugs & Organics (BOM:532637) YoY EBITDA Growth : 26.26% (As of Mar. 2025)

View and export this data going back to 2005. Start your Free Trial

What is Mangalam Drugs & Organics YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Mangalam Drugs & Organics's YoY EBITDA Growth for the quarter that ended in Mar. 2025 was 26.26%.

Mangalam Drugs & Organics's EBITDA per Share for the three months ended in Mar. 2025 was ₹6.57.

Mangalam Drugs & Organics YoY EBITDA Growth Historical Data

The historical data trend for Mangalam Drugs & Organics's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mangalam Drugs & Organics YoY EBITDA Growth Chart

Mangalam Drugs & Organics Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

YoY EBITDA Growth

Get a 7-Day Free Trial

162.40

-17.87

-75.68

59.15

107.89

Mangalam Drugs & Organics Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
YoY EBITDA Growth	Get a 7-Day Free Trial															-	-	819.97	28.99	26.26

Mangalam Drugs & Organics YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Mangalam Drugs & Organics's YoY EBITDA Growth for the fiscal year that ended in Mar. 2025 is calculated as:

	YoY EBITDA Growth (A: Mar. 2025 )
=	(EBITDA per Share (A: Mar. 2025 )	-	EBITDA per Share (A: Mar. 2024 ))	/	\| EBITDA per Share (A: Mar. 2024 ) \|
=	(22.972	-	11.05)	/	\| 11.05 \|
=	107.89 %

Mangalam Drugs & Organics's YoY EBITDA Growth for the quarter that ended in Mar. 2025 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2025 )
=	(EBITDA per Share (Q: Mar. 2025 )	-	EBITDA per Share (Q: Mar. 2024 ))	/	\| EBITDA per Share (Q: Mar. 2024 )) \|
=	(6.568	-	5.202)	/	\| 5.202 \|
=	26.26 %

Mangalam Drugs & Organics YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Mangalam Drugs & Organics's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Mangalam Drugs & Organics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mangalam Drugs & Organics Ltd (BOM:532637) » Definitions » YoY EBITDA Growth

Traded in Other Exchanges

MANGALAM:India

Address

P. D'Mello Road, Rupam Building, 3rd Floor, No. 239, Near General Post Office, Mumbai, MH, IND, 400001

Website

https://www.mangalamdrugs.com

Mangalam Drugs & Organics Ltd is an Indian company operating in the healthcare sector. The company is engaged in the research and development and manufacturing of drugs. Its product range includes Active Pharmaceutical Ingredients (APIs), Intermediates, and Specialty chemicals. Its sales comprise sales in the Indian and overseas markets. The single operating segment of the company is the Manufacturing of Bulk Drugs.

Mangalam Drugs & Organics Headlines

No Headlines